Loading people...
Kurt Akers is currently a Venture Advisor at Propellant Ventures based in Chicago, Illinois, where he evaluates and advises on early-stage startup investment opportunities. Over the past 10 years, he has operated as a startup founder, health advocate, and active investor specifically focused on the local Chicago technology and emerging cannabis sectors. Akers is deeply integrated into the regional entrepreneurial ecosystem through his ongoing involvement with the 1871 Chicago tech incubator, the RBL1 investor network, and the Flyover Tech community. He built his financial and operational foundation by earning a Master of Science in Finance from Cranfield University in England, following his earlier undergraduate academic studies as an alumnus of DePaul University. His current professional focus centers on guiding venture capital allocations and supporting emerging regional founders across the broader Midwest technology and cannabis landscapes.
Kurt Akers stands as a prominent investor at Endeavor Health Ventures, a leading organization dedicated to fostering innovation and growth within the dynamic healthcare sector. In his pivotal role, Akers is instrumental in identifying, evaluating, and supporting groundbreaking companies that are poised to redefine the future of health. His work at Endeavor Health Ventures involves a comprehensive approach, from initial market analysis and due diligence to strategic partnership development and active portfolio management, ensuring that investments not only yield financial returns but also drive meaningful advancements in patient care and industry efficiency.
Akers' investment focus at Endeavor Health Ventures is broad yet strategically targeted, encompassing a wide array of healthcare innovation. He is particularly interested in disruptive technologies and business models across areas such as digital health, including telemedicine and remote patient monitoring; biotechnology, with an emphasis on novel therapeutics and diagnostics; medical devices that enhance clinical outcomes; and health technology solutions that streamline operations and improve patient engagement. His expertise extends to understanding the complex regulatory landscape and market dynamics unique to the healthcare industry, allowing him to pinpoint ventures with high growth potential and sustainable impact.
Before joining Endeavor Health Ventures, Kurt Akers cultivated a robust career background that equipped him with a deep understanding of both finance and healthcare innovation. While specific details of his prior roles are not publicly disclosed, his trajectory likely involved significant experience in venture capital, private equity, or strategic development within the health sector. This foundation has provided him with a keen eye for identifying promising startups and established companies that possess strong leadership, innovative products, and scalable business models. His strategic insights are invaluable in guiding portfolio companies through critical growth stages, from product development to market expansion.
While specific notable investments attributed solely to Kurt Akers are typically proprietary to Endeavor Health Ventures' overall portfolio, his contributions are integral to the firm's success in backing transformative healthcare enterprises. Endeavor Health Ventures has a reputation for investing in pioneering companies that address unmet medical needs and improve healthcare delivery. Akers' involvement ensures that the firm continues to support ventures that are not only financially viable but also aligned with a mission to create a healthier future. His dedication to fostering innovation makes him a key figure in the venture capital landscape for healthcare.
Kurt Akers is an investor at Endeavor Health Ventures, specializing in strategic investments within the healthcare sector.
Kurt Akers primarily invests in healthcare innovation, including digital health, biotechnology, medical devices, and health technology solutions, through Endeavor Health Ventures.
Kurt Akers works as an investor at Endeavor Health Ventures, an organization focused on healthcare innovation and growth.
